Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab

INTRODUCTION: Anti-VEGF treatment has proven effective in recurrent ovarian cancer. However, the identification of the patients most likely to respond is still pending. It is well known that the angiogenesis is regulated by several other pro-angiogenic proteins, e.g. the platelet - derived growth fa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Madsen, Christine Vestergaard, Steffensen, Karina Dahl, Olsen, Dorte Aalund, Waldstrøm, Marianne, Smerdel, Maja, Adimi, Parvin, Brandslund, Ivan, Jakobsen, Anders
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2012
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3511256/
https://ncbi.nlm.nih.gov/pubmed/22989094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-2215-5-23
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares